INTRODUCTION
============

High-frequency oscillatory ventilation (HFOV) is now widely used as an artificial ventilator that actively performs 180−900 breaths per minute with a very small tidal volume (VT).[@B1] It is used as rescue therapy for severe respiratory failure in premature infants, and it contributes to reduce the incidence of bronchopulmonary dysplasia.[@B2][@B3][@B4][@B5]

The settings of the HFOV are based on the fraction of inspired oxygen (FiO~2~) for oxygen (O~2~) saturation, mean arterial pressure (MAP), which is about 2−4 cm H~2~O higher than the average airway pressure of conventional mechanical ventilation, amplitude of chest vibration to the umbilicus, and frequency of approximately 10−15 Hz.[@B6][@B7][@B8] On the basis of the carbon dioxide diffusion coefficient (DCO~2~) and VT, physicians can confirm the effect of oxygenation and ventilation.[@B9]

In particular, the DCO~2~ indicates the effectiveness of CO~2~ removal. It has various values depending on the size of the lung, and it is calculated as the product of the squared VT and the frequency.[@B10][@B11] Setting parameters in HFOV, according to the lung pathology, is left to the discretion of the physician, and appropriate DCO~2~ and VT values have not yet been established. When the DCO~2~ is below 40 mL^2^/s, it has been reported that the probability of a pCO~2~ below 50 mm Hg is estimated to be 49%, and the appropriate DCO~2~ value for extremely low-birth-weight (ELBW) infants has been reported as 18.5 mm Hg.[@B12] VT refers to VT averaged over several cycles, and it is generally recommended to set it to 1.5−2 mL/kg.[@B12] This, however, depends on the lung mechanics and ventilator mechanics, since the volume of the lung increases as the frequency of ventilation decreases. For greater lung compliance, an ideal VT should be maintained in order to prevent hyperinflation.[@B13] One study reported that the set VT values varied between from 1.46 mL/kg for ELBW infants and 1.57 mL/kg for infants weighing 1000−2000 g.[@B14] In another preterm study of infants \<32 weeks of gestation, the targeted VT ranged from 1.5 mL/kg to 2.5 mL/kg, and only 51% of infants had normocapnia.[@B12]

In the present study, we aim to analyze the respiratory mechanics, especially DCO~2~ values, VT, and minute volume and correlate them with plasma CO~2~ (pCO~2~) in very-low-birth-weight (VLBW) infants using HFOV.

MATERIALS AND METHODS
=====================

Patients
--------

This retrospective study comprised 20 VLBW infants, who received HFOV without volume guarantee for treatment of respiratory failure. These patients had all been admitted to the neonatal intensive care unit of Gangnam Severance Hospital between March 2015 and February 2016. Their two hundred seventeen results of blood gas analysis were collected. Ethical approval was obtained from the ethics committees of Gangnam Severance Hospital and informed consent was waived (IRB approval number; 3-2017-0120).

Ventilator
----------

HFOV was delivered using a Dräger Babylog VN500 ventilator (Drägerwerk Ag & Co., Lübeck, Germany) with a Venturi system. It generates active inspiration and active expiration to induce a sinusoidal pressure signal around a set mean airway pressure. The Dräger Babylog VN500 ventilator uses a double hot-wire anemometer, which has been demonstrated to be a very accurate way of measuring frequency of expired VT during HFOV, as there is greater linearity of response across a range of frequencies.[@B15]

Ventilation strategies
----------------------

HFOV was set as a mean airway pressure of 1 to 2 cm H~2~O higher than that received during conventional mechanical ventilation and the same inspired oxygen fraction. In chest radiograph, the lung volume was evaluated with the right diaphragm at the level of the ninth rib. A frequency of 10−12 Hz and an oscillatory inspiratory/expiratory ratio of 1:1 were used in all infants. An amplitude set above the mean airway pressure value was increased until visible chest wall movement up to the umbilicus level was noted.

If the PCO~2~ value was outside the target range, the amplitude was adjusted up or down in increments of 10−20% as necessary in the HFOV alone period. Capillary blood gases were measured 1 hour after applying HFOV and then at 6−8-hour intervals or more often as needed using a blood gas analyser. The FiO~2~ was given as needed to achieve a peripheral capillary oxygen saturation (SpO~2~) between 90% and 95% by pulse oximetry.

Data acquisition and analysis
-----------------------------

During ventilation, a hot-wire anemometer was placed on the airway opening to continuously measure the flow and VT during HFOV. The VT, Paw, minute volume, and DCO~2~ were calculated as VT^2^×frequency (mL^2^/s) by the ventilator (Dräger Babylog VN500 2.n software, Dräger) and recorded at 1 minute. Data from the ventilator were exported through a standard USB connection.

The following data were also collected from patients included in the study: demographic characteristics, perinatal pathology and treatment, clinical course, initial and final ventilator settings, vital signs, and capillary blood gas analysis. When analysing the blood gas analysis, pCO~2~ values between 45 and 55 mm Hg were considered normocapnia.

Statistical analysis
--------------------

Data were compared using the t-test and chi-square test. All statistical analyses were performed using SPSS for Windows, version 19.0 (IBM Corp., Armonk, NY, USA). A *p*-value \<0.05 was considered statistically significant.

RESULTS
=======

The study population consisted of 20 VLBW infants with a median gestational age of 28.3 weeks and median birth weight of 1050 g. The 1-minute Apgar score was 2.5, and the 5-minute Apgar score was 5.4 points. Age at the start of HFOV was 5.3 days, and the duration of HFOV was 10.3 days. Surfactant replacement therapy was administered to all the infants, and five infants received multiple therapy. No patients with congenital anomalies affecting the cardiac, respiratory or central nervous system were found. Eleven infants had a maternal history of chorioamnionitis, and 15 received steroid treatment ([Table 1](#T1){ref-type="table"}).

The ventilator parameters were set as follows: inspiratory-to-expiratory (I/E) time ratio, 1:1; frequency, 10.5 Hz; amplitude, 23.6 cm H~2~O; and MAP, 11.7 cm H~2~O. The measured VT was 1.7 mL/kg, minute volume was 0.7 mL/kg, and DCO~2~ was 43.5 mL^2^/s. Median results of the blood gas test were as follows: pH, 7.31; pCO~2~, 52.6 mm Hg; and SpO~2~, 90.5% ([Table 2](#T2){ref-type="table"}).

In a comparison of the normocapnia and hypercapnia groups, the VT, minute volume, and DCO~2~ were statistically significantly different. The mean VT of the normocapnia group was 2.1 mL/kg, minute volume was 0.9 mL/kg, and DCO~2~ was 68.4 mL^2^/s ([Table 3](#T3){ref-type="table"}). The relationship between pCO~2~ and DCO~2~ was negative. The correlation between the VT and pCO~2~ was also negative, shown in [Fig. 1](#F1){ref-type="fig"}. When we divided infants into 4 groups according to the DCO~2~ value, the percentage of infants with normocapnia corresponding to a pCO~2~ \<55 mm Hg was 83% for a DCO~2~ 40−60 mL^2^/s in each DCO~2~ group ([Table 4](#T4){ref-type="table"}). According to the receiver operating characteristic curves, the area under the curve for normocapnic status was 0.833 (*p*=0.041). The estimated optimal cut-off points to predict the remaining normocapnic status was a VT of 1.75 mL/kg (sensitivity 73%, specificity 80%) ([Fig. 2](#F2){ref-type="fig"}).

DISCUSSION
==========

HFOV is widely used as a treatment of choice and rescue therapy for respiratory failure in preterm infants. The use of elective HFOV can result in a reduction in the risk of chronic lung disease.[@B7] However, the respiratory mechanics in infants ventilated with the Dräger Babylog VN500 ventilator or other HFOV devices has much individual variance, thus few studies have reported appropriate data. The present study is meaningful, as it is the first one to assess the respiratory mechanics using the Dräger Babylog VN500 ventilator and to analyse the ventilation status of Korean VLBW infants.

Severe hypercapnia and hypocapnia may cause neonatal brain injury. These conditions can induce changes in the cerebral blood volume.[@B16] The association between hypocapnia and periventricular leukomalacia in preterm infants is well documented.[@B17][@B18] Severe hypercapnia is associated with organ dysfunction, including barotrauma, renal dysfunction, cardiovascular dysfunction, and an increased motality risk in the intensive care unit (odds ratio 1.93).[@B19] Furthermore, a high pCO~2~ value has been shown to be a risk factor for severe intraventricular haemorrhage.[@B20] Therefore, it is essential to maintain normocapnia in patients under ventilator care. However, frequent sampling to check the pCO~2~ level is limited in VLBW infants.

HFOV is effective for ventilation control compared to conventional mechanical ventilation.[@B21] Targeting the ideal DCO~2~ may induce a more stable PCO~2~ level, which has the potential to reduce both hypercarbia and hypocarbia. However, the DCO~2~ has various values depending on the size of the lung and underlying conditions, and the absolute target value has not yet been confirmed.[@B22] In a previous study, the mean values of DCO~2~ according to body weight were reported according to the weight ranges in extremely low birth weight infants, in those weighing between 1000 g and 2000 g, and in those weighing over 2000 g.[@B14] In the present study, we confirmed that DCO~2~ and pCO~2~ values were more useful to maintain normocapnia with proper ventilation than DCO~2~ values of above 40 mL^2^/s in VLBW infants. In a neonatal animal model, no significant changes on CO~2~ elimination are observed during HFOV with I/E ratios of 1:1 and 1:2 both.[@B23]

Considering the correlation between lung pressure and lung inflation, maintenance of adequate VT between under-inflation and over-inflation is essential to prevent barotrauma.[@B24][@B25] It has been reported that the VT improved CO~2~ elimination, and it had a greater effect than the frequency of ventilation.[@B23][@B26] HFOV is useful for maintaining the VT within the target range of normocapnia, and it is associated with a low incidence of hypocapnia and hypercapnia compared to conventional ventilation. The most important consideration is that the optimal initial value of VT is not yet clearly known. VT decreases with increasing frequency, and it increases with increasing compliance and the tracheal tube diameter. One study used a target VT of 2 mL/kg, as the expected dead space was thought to be approximately 2.2 mL/kg in healthy, awake neonates.[@B27]

To date, few studies have evaluated the optimal VT target in neonates during HFOV, because these values vary with gestational or postnatal age and underlying disease. In a study of infants who had been ventilated by HFOV at all time during their hospital days, the median gestation age was 27.2 weeks (range, 23.3−41.0 weeks) and respiratory distress syndrome (RDS) was most commonly diagnosed (56%), followed by lung hypoplasia (14%). The median delivered normocapnic VT during HFOV was 1.67 mL/kg, and the median suggested hypocapnic and hypercapnic VTs were 1.94 mL/kg and 1.54 mL/kg, respectively.[@B28] Other studies demonstrated that the median delivered normocapnic VT during HFOV was 1.74 mL/kg, median hypocapnic VT was 1.97 mL/kg, and median hypercapnic VT was 1.54 mL/kg in preterm infants during the initial phase of RDS.[@B12] A previous study showed that the adequate VT was 1.46 mL/kg for ELBW infants, 1.57 mL/kg for infants weighing 1000−2000 g, and 2.27 mL/kg for infants weighing over 2000 g. In the present study, the mean VT for normocapnia was 2.1 mL/kg, and the minute volume was 0.9 mL/kg in VLBW infants.[@B14]

Another study showed that an increase in VT from 2 to 3 mL/kg resulted in a decrease in the pCO~2~ level from 60±11 mm Hg to 51±8 mm Hg with concomitant increases in the amplitude and DCO~2~ in a newborn piglet model, and the DCO~2~ value was 68.4 mL^2^/s.[@B29] In this study, the correlation between the VT and pCO~2~ was also significantly negative.

The present study has a limitation in the exact analysis of normocapnia and hypercapnia because of the small number of patients and failure to distinguish between arterial, venous, and capillary blood. The individual variances about lung pathology and underlying condition were not adjusted. Because fixed frequency was not used though 10−12 Hz small ranges, the effect of decreased VT with increasing frequency was ignored. Actually, when the frequency changes from 10 Hz to 12 Hz, the dependency of oscillatory volume on frequency changes from 6.6 mL to 4.6 mL in 10 mbar MAP.[@B30] Because of the small number of patients, we couldn\'t divide the result of the blood test by frequency of the HFOV. We also examined only short-term physiological and respiratory variables; thus, the potential long-term benefits are only speculative.

In conclusion, it is advisable to maintain a normocapnia state with a VT of 1.75 mL/kg in VLBW infants and a DCO~2~ value of ≥40 mL^2^/s. Further studies are needed to establish this topic further.

This work was supported by a National Research Foundation of Korea grant, funded by the Korea government (Number 2011-0014207).

The authors have no financial conflicts of interest.

![Correlation analysis between DCO~2~ and pCO~2~ and between VT and pCO~2~. DCO~2~ values showed negative correlation with pCO~2~. VT showed negative correlation with pCO~2~. DCO~2~, carbon dioxide diffusion coefficient; pCO~2~, plasma CO~2~; VT, tidal volume.](ymj-59-101-g001){#F1}

![ROC curve analysis. On the ROC curve analysis, setting of the tidal volume at 1.75 mL/kg was able to maintain normocapnia with a sensitivity of 73%, specificity of 80%, and an AUC of 0.833. ROC, receiver operating characteristic curves; AUC, area under the curve.](ymj-59-101-g002){#F2}

###### Patient Characteristics

![](ymj-59-101-i001)

  Characteristics (n=20)                       Median (range)
  -------------------------------------------- -------------------
  Gestation age (wk)                           28.3 (23.8--33.1)
  Birth weight (g)                             1050 (620--1500)
  Male:Female                                  1:1.57
  Apgar score-1                                2.5 (1.0--5.0)
  Apgar score-5                                5.4 (3.0--8.0)
  Hospital day (d)                             68.6 (31--133)
  Age at the start of HFOV (days)              5.3 (2.0--21.0)
  Duration of HFOV (days)                      10.3 (4.0--30.0)
  Number of surfactant administration, n (%)   
   1                                           15 (75)
   2                                           3 (15)
   3                                           2 (5)
  Chorioamnionitis, n (%)                      11 (55)
  Antenatal steroid treatment, n (%)           15 (75)

HFOV, high-frequency oscillatory ventilation.

###### Ventilator Parameters and Results of Blood Gas Analysis

![](ymj-59-101-i002)

  Parameters and gas analysis (n=217)   Median (range)
  ------------------------------------- --------------------
  I:E                                   1:1
  Frequency (Hz)                        10.5 (9.0--12.0)
  Amplitude (cm H~2~O)                  23.6 (15.0--30.0)
  MAP (cm H~2~O)                        11.7 (7.0--15.0)
  FiO~2~                                0.46 (0.30--0.80)
  Tidal volume (mL/kg)                  1.7 (1.2--2.3)
  Minute volume (mL/kg)                 0.7 (0.2--1.2)
  DCO~2~ (mL^2^/sec)                    43.5 (20.5--88.3)
  pH                                    7.31 (7.08--7.51)
  pCO~2~ (mm Hg)                        52.6 (32.8--88.6)
  SpO~2~ (%)                            90.5 (82.0--100.0)

HFOV, high-frequency oscillatory ventilation; I:E, inspiratory-to-expiratory time ratio; MAP, mean arterial pressure; FiO~2~, fraction of inspired oxygen; DCO~2~, carbon dioxide diffusion coefficient; pCO~2~, plasma CO~2~; SpO~2~, peripheral capillary oxygen saturation.

###### Comparisons of Parameters between Normocapnia and Hypercapnia Group

![](ymj-59-101-i003)

  Parameters                         Normocapnia (n=105)   Hypercapnia (n=112)   *p* value
  ---------------------------------- --------------------- --------------------- -----------
  Frequency, mean (±SD, Hz)          11.2 (±1.2)           10.9 (±1.1)           0.035
  Amplitude, mean (±SD, cm H~2~O)    24.6 (±6.2)           23.7 (±4.2)           \<0.001
  MAP, mean (±SD, cm H~2~O)          11.9 (±5.3)           12.1 (±4.8)           \<0.018
  FiO~2~, mean (±SD)                 0.32 (±0.16)          0.49 (±0.14)          \<0.001
  Tidal volume, mean (±SD, mL/kg)    2.1 (±0.5)            1.6 (±0.3)            \<0.001
  Minute volume, mean (±SD, mL/kg)   0.9 (±0.2)            0.6 (±0.3)            \<0.001
  DCO~2~, mean (±SD, mL^2^/sec)      68.4 (±32.7)          32.4 (±15.7)          \<0.001
  SpO~2~, mean (±SD, %)              91.5 (±5.9)           90.1 (±4.9)           0.542

MAP, mean arterial pressure; FiO~2~, fraction of inspired oxygen; DCO~2~, carbon dioxide diffusion coefficient; SpO~2~, peripheral capillary oxygen saturation; SD, standard deviation.

###### Incidence of Normocapnia According to the DCO~2~ Value Ranges
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  DCO~2~ (mL^2^/sec)   pCO~2~ (below 55 mm Hg)
  -------------------- -------------------------
  \<40                 35% (19/55)
  40--60               83% (81/98)
  60--80               86% (38/44)
  \>80                 91% (21/23)

DCO~2~, carbon dioxide diffusion coefficient; pCO~2~, plasma CO~2~.
